Suchergebnisse - "KZK563J2UW"

PubPharm (22)

1

A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia : results of the LI-1 trial

enthalten in: British journal of haematology | 2021

von Dennis, M. | Burnett, A. | Hills, R. | +109

2

Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy

enthalten in: Leukemia & lymphoma | 2021

von Lee, S. | Desai, P. | Edirisinghe, B. | +5

3

Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AML

enthalten in: Blood advances | 2020

von Visani, G. | Loscocco, F. | Dennis, M. | +13

4

Discovery of Anticancer Clinical Candidate, Tosedostat, As an Analgesic Agent

enthalten in: ACS chemical neuroscience | 2019

von Singh, R. | Xie, W. | Williams, J. | +2

5

Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS

enthalten in: British journal of haematology | 2016

von Mawad, R. | Becker, P. | Hendrie, P. | +11

6

In Vitro Radiosensitization of Esophageal Cancer Cells with the Aminopeptidase Inhibitor CHR-2797

enthalten in: Radiation research | 2015

von Anbalagan, S. | Biasoli, D. | Leszczynska, K. | +2

7

The combination of HDAC and aminopeptidase inhibitors is highly synergistic in myeloma and leads to disruption of the NFκB signalling pathway

enthalten in: Oncotarget | 2015

von Smith, E. | Zhang, L. | Walker, B. | +7

8

X-ray crystal structures of an orally available aminopeptidase inhibitor, Tosedostat, bound to anti-malarial drug targets PfA-M1 and PfA-M17

enthalten in: Proteins | 2015

von Drinkwater, N. | Bamert, R. | Sivaraman, K. | +2

9

Response of single leukemic cells to peptidase inhibitor therapy across time and dose using a microfluidic device

enthalten in: Integrative biology : quantitative biosciences from nano to macro | 2014

von Kovarik, M. | Dickinson, A. | Roy, P. | +3

10

Tosedostat for the treatment of relapsed and refractory acute myeloid leukemia

enthalten in: Expert opinion on investigational drugs | 2014

von DiNardo, C. | Cortes, J.